Efficacy of safety of Natural Orifice Specimen Extraction:NOSE for Colorectal cancer

Efficacy of safety of Natural Orifice Specimen Extraction:NOSE for Colorectal cancer - Efficacy of safety of Natural Orifice Specimen Extraction:NOSE for Colorectal cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000040371

Enrollment

120

Registered

2020-07-08

Start date

2020-07-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Natural Orifice Specimen Extraction:NOSE

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing colorectal surgery for cStage 0 or I (location: C, A, T, D, S and RS)

Exclusion criteria

Exclusion criteria: 1)Patients with or suspicious of estrogen-dependent cancer (eg, breast cancer or gynecologic canbcer) 2)Participants with a history of any hypersensitivity to ingredients in HOLIN-V VAGINAL TABLETS 3)Patients who have the possibility of being pregnant

Design outcomes

Primary

Measure	Time frame
assessment of abdominal pain	—

Secondary

Measure	Time frame
Age, gender, BMI (Body Mass Index), comorbidity (eg, diabetes mellitus), sudden cessation of drugs (eg, steroids), intestinal obstruction, operation time, intraoperative blood loss, T factor, N factor, M factor, distance of anastomotic site from anal verge, rate of leakage, rate of intraperitoneal abscess, ate of bleeding after surgery, rate of interventional drainage, rate of relaparotomy, rate of stoma creation, SSI, rate of morbidity, length of drain insertion, hospital stay, mortality, rate of readmission, assessment of the QOL	—

Measure

Time frame

Age, gender, BMI (Body Mass Index), comorbidity (eg, diabetes mellitus), sudden cessation of drugs (eg, steroids), intestinal obstruction, operation time, intraoperative blood loss, T factor, N factor, M factor, distance of anastomotic site from anal verge, rate of leakage, rate of intraperitoneal abscess, ate of bleeding after surgery, rate of interventional drainage, rate of relaparotomy, rate of stoma creation, SSI, rate of morbidity, length of drain insertion, hospital stay, mortality, rate of readmission, assessment of the QOL

—

Countries

Japan

Contacts

Public ContactHiroki Hamamoto

Osaka Medical and Pharmaceutical University Department General and Gastroenterological Surgery

hiroki.hamamoto@ompu.ac.jp0726831221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026